company

STIFTELSEN INSTITUTT FOR EKSPERIMENTELL MEDISINSK FORSKNING

Return on Equity
−14,75 %
Current Ratio
6,08
Debt-to-Equity Ratio
0
Key figures (NOK)2022
Revenue−2 508 000
Net Income−4 853 000
Total Assets39 385 000
Total Equity32 902 000
Income (NOK)2022
Revenue−2 508 000
Expenditure89 000
Operating Profit−2 597 000
Financial Income0
Financial Costs2 256 000
Financial Balance−2 256 000
Earnings Before Tax−4 853 000
Tax0
Net Income−4 853 000
Balance (NOK)2022
Total Fixed Assets0
Total Current Assets39 385 000
Total Assets39 385 000
Total Retained Equity26 150 000
Total Equity32 902 000
Total Long-Term Debt0
Total Current Debt6 483 000
Total Equity and Debt39 385 000
Cash flow (NOK)2022
Sales Income0
Other Income−2 508 000
Revenue−2 508 000
Cost of Goods Sold0
Salary Costs82 000
Depreciation0
Impairment0
Expenditure89 000
Operating Profit−2 597 000
Financial Income0
Financial Costs2 256 000
Financial Balance−2 256 000
Dividends0
Net Income−4 853 000
Balance details (NOK)2022
Goodwill0
Total Intangible Assets0
Real Eastate0
Machinery and Plant Facilities0
Fixtures0
Total Tangible Assets0
Total Fiancial Fixed Assets0
Total Fixed Assets0
Stock0
Total Investments31 245 000
Cash, Bank8 139 000
Total Current Assets39 385 000
Total Assets39 385 000
Total Equity32 902 000
Short-Term Group Debt0
Total Long-Term Debt0
Creditors112 000
Unpaid Taxes0
Dividends0
Other Current Debt6 370 000
Total Current Debt6 483 000
Total Equity and Debt39 385 000
Financial indicators2022
Return on Equity−14,75 %
Debt-to-Equity Ratio0
Operating Profit Margin103,55 %
Current Ratio6,08
Quick Ratio6,08
Equity Ratio0,84
Gross Profit Margin100 %
RotateRotate your device to see the full table
HomeIndustriesNew CompaniesAbout
🇳🇴Norsk🇬🇧English